share_log
Moomoo 24/7 ·  Feb 28 11:07
Zentalis Pharmaceuticals Shares Are Trading Higher After Wedbush Maintained a Neutral Rating on the Stock and Raised Its Price Target From $12 to $15
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment